[MP-202418] Senaparib (ovarian cancer)
Project no.:
MP-202418
Report type:
Status:
Commission work started
Department/Division:
Drug Assessment
Topic:
Cancer
Indication:
Maintenance treatment of advanced epithelial high-grade ovarian, fallopian tube or primary peritoneal cancer
Note:
This Joint Clinical Assessment (JCA) is being conducted in cooperation with the Slovenian Quality Health Care Agency.
Further background information can be found here: European health technology assessment
| Stage | Date |
|---|---|
| 3rd quarter, 2025 | |
| 3rd quarter, 2026 |